Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 4Breast 3Plasma cell 2CNS 2Thoracic 1Sarcoma 1Other neoplasm 1Myeloid 1Gynecologic 1Dermatologic 1Classical hematology 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 76Sarcoma 72Burkitt Lymphoma 59Lymphoma 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Lymphoma, Large B-Cell, Diffuse 54Lymphoma, Non-Hodgkin 53Lymphoma, Follicular 49Lymphoma, Mantle-Cell 48Leukemia 48Lymphoma, Large-Cell, Immunoblastic 47Leukemia, Lymphocytic, Chronic, B-Cell 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Acute 43Hodgkin Disease 42Myelodysplastic Syndromes 41Multiple Myeloma 40Recurrence 39Leukemia, Myeloid, Chronic-Phase 32Leukemia, Myeloid, Accelerated Phase 31Blast Crisis 30Neoplasms, Plasma Cell 28Sarcoma, Ewing 25Rhabdomyosarcoma 25Osteosarcoma 24Myeloproliferative Disorders 24Neuroblastoma 23Leukemia, Myelomonocytic, Chronic 21Congenital Abnormalities 21Melanoma 20

Interventions

apatinib 4Ifosfamide 2Filgrastim 2Etoposide 2selinexor 1glucarpidase 1camrelizumab 1Vincristine 1Radiotherapy 1Procarbazine 1Pharmaceutical Preparations 1Methotrexate 1Lomustine 1Imatinib Mesylate 1Genetic Therapy 1Fibroblast Growth Factor 7 1Drug Combinations 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Cyclophosphamide × Sarcoma × Clear all
NCT00004132 2013-06-26

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

National Cancer Institute (NCI)

Phase 2 Completed
LymphoidOther hematologic neoplasmPlasma cellSarcoma

Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Radiation Injuries, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡